All Stories

  1. ChatGPT as an information tool in rhinology. Can we trust each other today?
  2. Editorial: Benign paroxysmal positional vertigo
  3. Clinical practice guideline on the management of vestibular schwannoma
  4. Bow and Lean Test for Rare Variants of Vertical Semicircular Canal BPPV
  5. Audiovestibular Manifestations in Patients with Primary Raynaud’s Phenomenon and Raynaud’s Phenomenon Secondary to Systemic Sclerosis
  6. Letter to the editor about “Pulmonary invasive fungal infection and rhinofacial cellulitis with paranasal sinus and orbital fossa invasion in an inmunocompromised patient”
  7. Carta al editor con relación a «Infección fúngica invasiva pulmonar y celulitis rinofacial con invasión de senos paranasales y fosa orbitaria en paciente inmunodeprimido»
  8. Trend changes in the incidence of benign parotid tumours in the last 30 years in a Spanish population
  9. Long-Term Evolution of Vestibular Compensation, Postural Control, and Perceived Disability in a Population of Patients with Vestibular Neuritis
  10. Low-Dose Intratympanic Gentamicin for Unilateral Ménière‘s Disease: Accuracy of Early Vestibulo-Ocular Reflex Gain Reduction in Predicting Long-Term Clinical Outcome
  11. Clinical Subtypes and vHIT Parameters in a Population With Bilateral Vestibulopathy
  12. Protocolo de vértigo de origen dudoso
  13. Vibration-induced nystagmus and head impulse test screening for vestibular schwannoma
  14. Prospective Study in 355 Patients With Suspected COVID‐19 Infection: Value of Cough, Subjective Hyposmia, and Hypogeusia
  15. Reply to the Letter to the Editor, “Tracheostomy in the COVID‐19 Era: The Apneic Approach”
  16. Safety and Prognosis in Percutaneous vs Surgical Tracheostomy in 27 Patients With COVID‐19
  17. Relevance of Artifact Removal and Number of Stimuli for Video Head Impulse Test Examination
  18. Corrigendum: Clinical Features of Headache in Patients With Diagnosis of Definite Vestibular Migraine: The VM-Phenotypes Projects
  19. La depresión de la investigación en otorrinolaringología en España tiene solución
  20. Oscillopsia in Bilateral Vestibular Hypofunction: Not Only Gain But Saccades Too
  21. Differential Proinflammatory Signature in Vestibular Migraine and Meniere Disease
  22. Gain restoration after gentamicin
  23. Clinical Features of Headache in Patients With Diagnosis of Definite Vestibular Migraine: The VM-Phenotypes Projects
  24. La exploración, nuestra mejor aliada
  25. Prevalence and management of post-BPPV residual symptoms
  26. Proinflammatory cytokines and response to molds in mononuclear cells of patients with Meniere disease
  27. La investigacion en ORL en España 2011-2015
  28. Regulation of Fn14 Receptor and NF-κB Underlies Inflammation in Meniere’s Disease
  29. Clinical Features, Familial History, and Migraine Precursors in Patients With Definite Vestibular Migraine: The VM-Phenotypes Projects
  30. BCG immune activation reduces growth and angiogenesis in an in vitro model of head and neck squamous cell carcinoma
  31. The Role of Predictability in Saccadic Eye Responses in the Suppression Head Impulse Test of Horizontal Semicircular Canal Function
  32. Guía de Práctica Clínica Para el Diagnóstico y Tratamiento del Vértigo Posicional Paroxístico Benigno. Documento de Consenso de la Comisión de Otoneurología Sociedad Española de Otorrinolaringlogía y Cirugía de Cabeza y Cuello
  33. Vestibular Restoration and Adaptation in Vestibular Neuritis and Ramsay Hunt Syndrome With Vertigo
  34. Postural stability in a population of dancers, healthy non-dancers, and vestibular neuritis patients
  35. Clinical subgroups in unilateral Meniere disease
  36. Clinical Subgroups in Bilateral Meniere Disease
  37. Protective effect of polyphenols on presbycusis via oxidative/nitrosative stress suppression in rats
  38. Therapeutic illusion: another frontier in Ménière’s disease
  39. High-frequency sensorineural hearing loss associated with vestibular episodic syndrome
  40. Nistagmo vertical inferior: ¿es obligada la resonancia magnética?
  41. Encuesta sobre la situación de la otoneurología en España
  42. Accuracy of auditory steady state and auditory brainstem responses to detect the preventive effect of polyphenols on age-related hearing loss in Sprague–Dawley rats
  43. Endolymphatic hydrops and intratympanic steroids
  44. Intronic Variants in the NFKB1 Gene May Influence Hearing Forecast in Patients with Unilateral Sensorineural Hearing Loss in Meniere's Disease
  45. Utility of auditory steady-state and brainstem responses in age-related hearing loss in rats
  46. Value of clinical data and vestibular testing in a population of 101 patients with recurrent vestibulopathy
  47. Control of Vertigo After Intratympanic Corticoid Therapy for Unilateral Ménière’s Disease
  48. The use of electrocochleography to monitor the response of Ménière's disease patients to intratympanic steroids
  49. Control of Vertigo After Intratympanic Corticoid Therapy for Unilateral Ménière’s Disease
  50. Familial clustering and genetic heterogeneity in Meniere's disease
  51. Allelic variants in TLR10 gene may influence bilateral affectation and clinical course of Meniere’s disease
  52. Benign Paroxysmal Positional Vertigo in the Elderly
  53. Electrococleografía extratimpánica en la enfermedad de Ménière
  54. Ginkgo biloba extract (EGb761) protects against aging-related caspase-mediated apoptosis in rat cochlea
  55. Valor de las pruebas de control postural dinámico de la posturografía en ancianos con vestibulopatía
  56. Value of dynamic postural control tests on elderly people with vestibulopathy
  57. Posturografía estática frente a pruebas clínicas en ancianos con vestibulopatía
  58. Static Posturography Versus Clinical Tests in Elderly People With Vestibular Pathology
  59. Vértigo paroxístico benigno infantil: categorización y comparación con el vértigo posicional paroxístico benigno del adulto
  60. Benign Paroxysmal Vertigo of Childhood: Categorization and Comparison With Benign Positional Paroxysmal Vertigo in Adult
  61. Distortion Product Otoacoustic Emissions after Intratympanic Gentamicin Therapy for Unilateral Ménière’s Disease
  62. Gentamicina intratimpánica para la enfermedad de ménière: análisis de la técnica
  63. Análisis de la interacción visuo-vestibular y la influencia visual en el control postural
  64. Hearing Loss after Intratympanic Gentamicin Therapy for Unilateral M??ni??re's Disease
  65. Results of Vestibular Autorotation Testing at the End of Intratympanic Gentamicin Treatment for Méniére's Disease
  66. Intratympanic Gentamicin for Intractable Meniere???s Disease
  67. Dizziness: Relating the Severity of Vertigo to the Degree of Handicap by Measuring Vestibular Impairment
  68. Benign Paroxysmal Positional Vertigo in Patients With M??ni??re???s Disease Treated With Intratympanic Gentamycin
  69. Influence of Canal Paresis and Compensation on Gain and Time Constant of Nystagmus Slow-phase Velocity to Yaw-axis Rotation
  70. Factor Analysis and Correlation Between Dizziness Handicap Inventory and Dizziness Characteristics and Impact on Quality of Life Scales